US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 6.400
  • +0.080+1.27%
Close Nov 1 16:00 ET
  • 6.489
  • +0.089+1.39%
Post 20:01 ET
1.87BMarket Cap-3855P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.87%-82.22M
-39.53%-102.3M
-244.55%-287.78M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
47.34%-83.52M
26.83%-44.75M
-65.04%-54.54M
Net income from continuing operations
-27.13%-97.54M
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
-28.42%-239.48M
11.46%-57.49M
-27.45%-60.45M
Depreciation and amortization
61.79%8.97M
97.88%7.38M
107.57%24.4M
135.00%7.55M
153.53%7.58M
98.96%5.54M
34.73%3.73M
39.87%11.76M
43.74%3.21M
22.70%2.99M
Other non cash items
-95.41%93K
-29.29%1.91M
33.76%11.45M
168.88%6.55M
-90.41%170K
-8.20%2.03M
26.12%2.7M
108.93%8.56M
110.54%2.44M
282.11%1.77M
Change In working capital
-1.41%-10.26M
-49.36%-36.45M
-147.90%-50.26M
-1,775.21%-11.27M
42.54%-4.46M
-6.12%-10.12M
-119.87%-24.4M
34,387.91%104.92M
84.82%-601K
-206.52%-7.77M
-Change in receivables
190.42%736K
-228.08%-1.04M
-387,700.00%-7.76M
-215.25%-6.42M
-105.37%-203K
54.78%-814K
95.80%-317K
99.96%-2K
306.72%5.57M
186.15%3.78M
-Change in payables and accrued expense
-10.45%4.26M
-88.89%-17.96M
392.53%8.44M
-50.65%4.78M
131.91%8.41M
207.30%4.76M
27.67%-9.51M
-88.63%1.71M
442.35%9.69M
-74.42%3.63M
-Change in other current liabilities
12.47%-2.62M
-55.24%-3.79M
-38.71%-9.86M
12.41%-1.91M
-18.58%-2.51M
-93.79%-3M
-93.20%-2.44M
---7.11M
---2.18M
---2.12M
-Change in other working capital
-14.19%-12.64M
-12.54%-13.66M
-137.23%-41.08M
43.58%-7.72M
22.16%-10.16M
-43.01%-11.07M
-108.38%-12.13M
1,203.20%110.32M
-447.00%-13.68M
-422.12%-13.05M
Cash from discontinued investing activities
Operating cash flow
-21.87%-82.22M
-39.53%-102.3M
-244.55%-287.78M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
47.34%-83.52M
26.83%-44.75M
-65.04%-54.54M
Investing cash flow
Cash flow from continuing investing activities
-103.70%-4.18M
-24.59%-6.65M
-105.29%-10.23M
68.82%-2.49M
-100.65%-347K
-141.56%-2.05M
-103.73%-5.34M
171.11%193.25M
84.73%-7.98M
127.33%52.98M
Net PPE purchase and sale
70.21%-1.18M
-28.56%-6.65M
67.74%-11.96M
74.09%-2.07M
90.98%-745K
75.92%-3.97M
-19.18%-5.18M
6.88%-37.06M
-78.74%-7.98M
14.87%-8.26M
Net intangibles purchase and sale
---3M
--0
-99.00%-597K
---350K
72.67%-82K
--0
---165K
---300K
--0
---300K
Net business purchase and sale
----
----
--1.84M
---71K
--0
----
----
--0
--0
--0
Net investment purchase and sale
----
----
-99.79%480K
--0
----
----
----
199.42%230.61M
--0
133.42%61.55M
Cash from discontinued investing activities
Investing cash flow
-103.70%-4.18M
-24.59%-6.65M
-105.29%-10.23M
68.82%-2.49M
-100.65%-347K
-141.56%-2.05M
-103.73%-5.34M
171.11%193.25M
84.73%-7.98M
127.33%52.98M
Financing cash flow
Cash flow from continuing financing activities
6,848.03%263.12M
623.05%13.9M
-9.21%140.13M
-45.23%80.66M
2,200.60%53.77M
41.94%3.79M
-7.77%1.92M
-66.34%154.35M
3,779.24%147.26M
121.06%2.34M
Net issuance payments of debt
-8.33%-26K
-8.33%-26K
-751.11%-766K
-2,917.39%-694K
-4.35%-24K
-9.09%-24K
-9.09%-24K
99.30%-90K
-9.52%-23K
99.82%-23K
Net common stock issuance
--261.55M
--10.87M
-10.87%128.09M
-45.66%78.09M
--50M
--0
--0
-68.95%143.71M
--143.71M
----
Proceeds from stock option exercised by employees
-57.96%1.6M
56.73%3.05M
19.41%12.81M
-8.63%3.26M
60.55%3.79M
41.67%3.81M
-7.60%1.95M
27.11%10.72M
-6.52%3.57M
43.73%2.36M
Cash from discontinued financing activities
Financing cash flow
6,848.03%263.12M
623.05%13.9M
-9.21%140.13M
-45.23%80.66M
2,200.60%53.77M
41.94%3.79M
-7.77%1.92M
-66.34%154.35M
3,779.24%147.26M
121.06%2.34M
Net cash flow
Beginning cash position
-36.53%306.15M
-28.20%401.43M
89.31%559.11M
-14.56%397.21M
-10.19%416.82M
-6.90%482.38M
89.31%559.11M
10.55%295.35M
14.80%464.89M
-27.82%464.11M
Current changes in cash
368.85%176.72M
-23.88%-95.06M
-159.79%-157.88M
-95.67%4.09M
-2,600.26%-19.5M
-21.69%-65.73M
-134.44%-76.73M
837.02%264.07M
186.25%94.53M
100.33%780K
Effect of exchange rate changes
-165.19%-118K
-10,850.00%-219K
161.24%188K
140.39%124K
---115K
--181K
---2K
---307K
---307K
--0
End cash Position
15.82%482.75M
-36.53%306.15M
-28.20%401.43M
-28.20%401.43M
-14.56%397.21M
-10.19%416.82M
-6.90%482.38M
89.31%559.11M
89.31%559.11M
14.80%464.89M
Free cash flow
-20.95%-86.4M
-38.52%-108.95M
-148.45%-300.33M
-45.08%-76.49M
-16.87%-73.75M
8.53%-71.44M
-207.68%-78.66M
39.07%-120.88M
19.65%-52.73M
-47.60%-63.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.87%-82.22M-39.53%-102.3M-244.55%-287.78M-65.54%-74.08M-33.70%-72.92M-9.48%-67.47M-194.74%-73.32M47.34%-83.52M26.83%-44.75M-65.04%-54.54M
Net income from continuing operations -27.13%-97.54M-39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M-28.42%-239.48M11.46%-57.49M-27.45%-60.45M
Depreciation and amortization 61.79%8.97M97.88%7.38M107.57%24.4M135.00%7.55M153.53%7.58M98.96%5.54M34.73%3.73M39.87%11.76M43.74%3.21M22.70%2.99M
Other non cash items -95.41%93K-29.29%1.91M33.76%11.45M168.88%6.55M-90.41%170K-8.20%2.03M26.12%2.7M108.93%8.56M110.54%2.44M282.11%1.77M
Change In working capital -1.41%-10.26M-49.36%-36.45M-147.90%-50.26M-1,775.21%-11.27M42.54%-4.46M-6.12%-10.12M-119.87%-24.4M34,387.91%104.92M84.82%-601K-206.52%-7.77M
-Change in receivables 190.42%736K-228.08%-1.04M-387,700.00%-7.76M-215.25%-6.42M-105.37%-203K54.78%-814K95.80%-317K99.96%-2K306.72%5.57M186.15%3.78M
-Change in payables and accrued expense -10.45%4.26M-88.89%-17.96M392.53%8.44M-50.65%4.78M131.91%8.41M207.30%4.76M27.67%-9.51M-88.63%1.71M442.35%9.69M-74.42%3.63M
-Change in other current liabilities 12.47%-2.62M-55.24%-3.79M-38.71%-9.86M12.41%-1.91M-18.58%-2.51M-93.79%-3M-93.20%-2.44M---7.11M---2.18M---2.12M
-Change in other working capital -14.19%-12.64M-12.54%-13.66M-137.23%-41.08M43.58%-7.72M22.16%-10.16M-43.01%-11.07M-108.38%-12.13M1,203.20%110.32M-447.00%-13.68M-422.12%-13.05M
Cash from discontinued investing activities
Operating cash flow -21.87%-82.22M-39.53%-102.3M-244.55%-287.78M-65.54%-74.08M-33.70%-72.92M-9.48%-67.47M-194.74%-73.32M47.34%-83.52M26.83%-44.75M-65.04%-54.54M
Investing cash flow
Cash flow from continuing investing activities -103.70%-4.18M-24.59%-6.65M-105.29%-10.23M68.82%-2.49M-100.65%-347K-141.56%-2.05M-103.73%-5.34M171.11%193.25M84.73%-7.98M127.33%52.98M
Net PPE purchase and sale 70.21%-1.18M-28.56%-6.65M67.74%-11.96M74.09%-2.07M90.98%-745K75.92%-3.97M-19.18%-5.18M6.88%-37.06M-78.74%-7.98M14.87%-8.26M
Net intangibles purchase and sale ---3M--0-99.00%-597K---350K72.67%-82K--0---165K---300K--0---300K
Net business purchase and sale ----------1.84M---71K--0----------0--0--0
Net investment purchase and sale ---------99.79%480K--0------------199.42%230.61M--0133.42%61.55M
Cash from discontinued investing activities
Investing cash flow -103.70%-4.18M-24.59%-6.65M-105.29%-10.23M68.82%-2.49M-100.65%-347K-141.56%-2.05M-103.73%-5.34M171.11%193.25M84.73%-7.98M127.33%52.98M
Financing cash flow
Cash flow from continuing financing activities 6,848.03%263.12M623.05%13.9M-9.21%140.13M-45.23%80.66M2,200.60%53.77M41.94%3.79M-7.77%1.92M-66.34%154.35M3,779.24%147.26M121.06%2.34M
Net issuance payments of debt -8.33%-26K-8.33%-26K-751.11%-766K-2,917.39%-694K-4.35%-24K-9.09%-24K-9.09%-24K99.30%-90K-9.52%-23K99.82%-23K
Net common stock issuance --261.55M--10.87M-10.87%128.09M-45.66%78.09M--50M--0--0-68.95%143.71M--143.71M----
Proceeds from stock option exercised by employees -57.96%1.6M56.73%3.05M19.41%12.81M-8.63%3.26M60.55%3.79M41.67%3.81M-7.60%1.95M27.11%10.72M-6.52%3.57M43.73%2.36M
Cash from discontinued financing activities
Financing cash flow 6,848.03%263.12M623.05%13.9M-9.21%140.13M-45.23%80.66M2,200.60%53.77M41.94%3.79M-7.77%1.92M-66.34%154.35M3,779.24%147.26M121.06%2.34M
Net cash flow
Beginning cash position -36.53%306.15M-28.20%401.43M89.31%559.11M-14.56%397.21M-10.19%416.82M-6.90%482.38M89.31%559.11M10.55%295.35M14.80%464.89M-27.82%464.11M
Current changes in cash 368.85%176.72M-23.88%-95.06M-159.79%-157.88M-95.67%4.09M-2,600.26%-19.5M-21.69%-65.73M-134.44%-76.73M837.02%264.07M186.25%94.53M100.33%780K
Effect of exchange rate changes -165.19%-118K-10,850.00%-219K161.24%188K140.39%124K---115K--181K---2K---307K---307K--0
End cash Position 15.82%482.75M-36.53%306.15M-28.20%401.43M-28.20%401.43M-14.56%397.21M-10.19%416.82M-6.90%482.38M89.31%559.11M89.31%559.11M14.80%464.89M
Free cash flow -20.95%-86.4M-38.52%-108.95M-148.45%-300.33M-45.08%-76.49M-16.87%-73.75M8.53%-71.44M-207.68%-78.66M39.07%-120.88M19.65%-52.73M-47.60%-63.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept NVIDIA Portfolio
NVIDIA Portfolio
Intraday+0.17%